Perfusion cardiovascular magnetic resonance and fractional flow reserve in patients with angiographic multi-vessel coronary artery disease

[1] Hachamovitch R(2003)Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography Circulation 107 2900-7

[2] Hayes SW(2008)Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy Circulation 117 1283-91

[3] Friedman JD(2011)High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve J Am Coll Cardiol 57 70-5

[4] Cohen I(2008)High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease Eur Heart J 29 2148-55

[5] Berman DS(2012)Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial Lancet 379 453-60

[6] Shaw LJ(2009)Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 213-24

[7] Berman DS(2009)Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease Circulation 120 2207-13

[8] Maron DJ(1992)Noninvasive identification of severe coronary artery disease using exercise tomographic thallium-201 imaging Am J Cardiol 70 14-20

[9] Lockie T(2010)Comparison of stress perfusion MRI and SPECT for detection of myocardial ischemia in patients with angiographically proven three-vessel coronary artery disease AJR Am J Roentgenol 195 356-62

[10] Ishida M(2010)Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease JACC Cardiovasc Interv 3 307-14

[1] Hachamovitch R(2003)Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography Circulation 107 2900-7

[2] Hayes SW(2008)Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy Circulation 117 1283-91

[3] Friedman JD(2011)High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve J Am Coll Cardiol 57 70-5

[4] Cohen I(2008)High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease Eur Heart J 29 2148-55

[5] Berman DS(2012)Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial Lancet 379 453-60

[6] Shaw LJ(2009)Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 213-24

[7] Berman DS(2009)Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease Circulation 120 2207-13

[8] Maron DJ(1992)Noninvasive identification of severe coronary artery disease using exercise tomographic thallium-201 imaging Am J Cardiol 70 14-20

[9] Lockie T(2010)Comparison of stress perfusion MRI and SPECT for detection of myocardial ischemia in patients with angiographically proven three-vessel coronary artery disease AJR Am J Roentgenol 195 356-62

[10] Ishida M(2010)Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease JACC Cardiovasc Interv 3 307-14